SCHEMBL7693183

SCHEMBL7693183

NC(=O)C1(C(=O)OCCc2ccccc2)CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ ITGB3 P05106 2/20 0.40
▸ ITGAV P06756 2/20 0.40
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ GAA P10253 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ RAB9A P51151 7/20 0.39
▸ NPC1 O15118 6/20 0.39
▸ PKM P14618 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676699 0.91 ITGB3 (0.46) KCNH2ALDH1A1MAPK1HSD17B10CYP3A4
SCHEMBL7669079 0.71 SMN1; SMN2 (0.57) KCNH2ALDH1A1MAPK1HSD17B10SMN1; SMN2
SCHEMBL28406604 0.69 HDAC6 (0.57) KCNH2SMN1; SMN2RAB9ANPC1POLB
SCHEMBL7544328 0.69 SMN1; SMN2 (0.63) ALDH1A1MAPK1HSD17B10CYP3A4ITGB3
SCHEMBL7172907 0.69 SMN1; SMN2 (0.63) ALDH1A1MAPK1HSD17B10CYP3A4ITGB3
SCHEMBL7082045 0.69 SMN1; SMN2 (0.63) ALDH1A1MAPK1HSD17B10CYP3A4ITGB3
SCHEMBL11266594 0.69 KCNH2 (0.80) KCNH2SMN1; SMN2GAAMAPTL3MBTL1
SCHEMBL7085654 0.69 SMN1; SMN2 (0.59) ALDH1A1MAPK1HSD17B10ITGB3ITGAV
SCHEMBL7085647 0.69 SMN1; SMN2 (0.59) ALDH1A1MAPK1HSD17B10ITGB3ITGAV
SCHEMBL7089468 0.69 SMN1; SMN2 (0.59) ALDH1A1MAPK1HSD17B10ITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 — — US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 — — US disclosed
Send feedback